584 related articles for article (PubMed ID: 18753360)
1. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.
Alacacioglu A; Somali I; Simsek I; Astarcioglu I; Ozkan M; Camci C; Alkis N; Karaoglu A; Tarhan O; Unek T; Yilmaz U
Jpn J Clin Oncol; 2008 Oct; 38(10):683-8. PubMed ID: 18753360
[TBL] [Abstract][Full Text] [Related]
2. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
5. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
9. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
12. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
13. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
[TBL] [Abstract][Full Text] [Related]
14. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Yano Y; Yamashita F; Kuwaki K; Fukumori K; Kato O; Yamamoto H; Ando E; Tanaka M; Sata M
Liver Int; 2006 Sep; 26(7):789-95. PubMed ID: 16911460
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
Stuart KE; Anand AJ; Jenkins RL
Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
[TBL] [Abstract][Full Text] [Related]
17. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
[TBL] [Abstract][Full Text] [Related]
18. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Peng YC; Chan CS; Chen GH
Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
[TBL] [Abstract][Full Text] [Related]
20. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
